Difference between revisions of "Example orders for FOLFIRI in colon cancer"
Jump to navigation
Jump to search
m (Text replace - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.''' {{TOC limit|limit=3}}" to "'''Use of this site is subject to you read) |
Warner-admin (talk | contribs) m (Text replacement - "Folinic acid (Leucovorin)" to "Leucovorin (Folinic acid)") |
||
| (16 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | '''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]].''' | + | <!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''--> |
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | ||
| Line 10: | Line 10: | ||
Original references may be found at [[Colon_cancer#FOLFIRI|FOLFIRI]] | Original references may be found at [[Colon_cancer#FOLFIRI|FOLFIRI]] | ||
===Example regimen #1=== | ===Example regimen #1=== | ||
| − | *[[Folinic acid | + | *[[Leucovorin (Folinic acid)]] 400 mg/m<sup>2</sup> IV over 2 hours on day 1, given during irinotecan infusion |
| − | *[[Fluorouracil (5-FU)]] 400 mg/ | + | *[[Fluorouracil (5-FU)]] 400 mg/m<sup>2</sup> IV bolus over 10-15 minutes on day 1, given after irinotecan and leucovorin |
| − | *[[Fluorouracil (5-FU)]] 1200 mg/ | + | *[[Fluorouracil (5-FU)]] 1200 mg/m<sup>2</sup>/day IV continuous infusion over 46 hours on days 1 to 2, given last after bolus 5-FU |
| − | *[[Irinotecan (Camptosar)]] 180 mg/ | + | *[[Irinotecan (Camptosar)]] 180 mg/m<sup>2</sup> IV over 90 minutes on day 1, given first together with leucovorin |
'''14-day cycles''' | '''14-day cycles''' | ||
| − | Supportive | + | ====Supportive therapy==== |
*Ondansetron (Zofran) 8 mg IV 30 minutes prior to chemotherapy | *Ondansetron (Zofran) 8 mg IV 30 minutes prior to chemotherapy | ||
*[[Dexamethasone (Decadron)]] 10 mg IV 30 minutes prior to chemotherapy | *[[Dexamethasone (Decadron)]] 10 mg IV 30 minutes prior to chemotherapy | ||
| − | *Lorazepam (Ativan) 0.5-1 mg PO | + | *Lorazepam (Ativan) 0.5-1 mg IV or PO prn nausea/anxiety |
| − | *Atropine 0.4 mg IV prn diaphoresis, visual changes, abdominal cramping, or diarrhea during or after irinotecan infusion | + | *Atropine 0.4 mg IV prn diaphoresis, visual changes, abdominal cramping, or diarrhea during or after irinotecan infusion |
Monitoring: | Monitoring: | ||
| − | *Hold if ANC | + | *Hold if ANC less than 1000 or platelets less than 100 and notify physician. |
Outpatient medications: | Outpatient medications: | ||
*Loperamide (Imodium) 4 mg PO x1 for each day's first episode of diarrhea; 2 mg PO prn each loose stool thereafter, up to a maximum of 16 mg per day | *Loperamide (Imodium) 4 mg PO x1 for each day's first episode of diarrhea; 2 mg PO prn each loose stool thereafter, up to a maximum of 16 mg per day | ||
[[Category:Example chemotherapy order sets]] | [[Category:Example chemotherapy order sets]] | ||
Latest revision as of 15:39, 29 September 2023
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.
FOLFIRI
FOLFIRI: FOLinic acid, Fluorouracil, IRInotecan
Original references may be found at FOLFIRI
Example regimen #1
- Leucovorin (Folinic acid) 400 mg/m2 IV over 2 hours on day 1, given during irinotecan infusion
- Fluorouracil (5-FU) 400 mg/m2 IV bolus over 10-15 minutes on day 1, given after irinotecan and leucovorin
- Fluorouracil (5-FU) 1200 mg/m2/day IV continuous infusion over 46 hours on days 1 to 2, given last after bolus 5-FU
- Irinotecan (Camptosar) 180 mg/m2 IV over 90 minutes on day 1, given first together with leucovorin
14-day cycles
Supportive therapy
- Ondansetron (Zofran) 8 mg IV 30 minutes prior to chemotherapy
- Dexamethasone (Decadron) 10 mg IV 30 minutes prior to chemotherapy
- Lorazepam (Ativan) 0.5-1 mg IV or PO prn nausea/anxiety
- Atropine 0.4 mg IV prn diaphoresis, visual changes, abdominal cramping, or diarrhea during or after irinotecan infusion
Monitoring:
- Hold if ANC less than 1000 or platelets less than 100 and notify physician.
Outpatient medications:
- Loperamide (Imodium) 4 mg PO x1 for each day's first episode of diarrhea; 2 mg PO prn each loose stool thereafter, up to a maximum of 16 mg per day